82 related articles for article (PubMed ID: 30135483)
1. KRAS
Principe DR; Overgaard NH; Park AJ; Diaz AM; Torres C; McKinney R; Dorman MJ; Castellanos K; Schwind R; Dawson DW; Rana A; Maker A; Munshi HG; Rund LA; Grippo PJ; Schook LB
Sci Rep; 2018 Aug; 8(1):12548. PubMed ID: 30135483
[TBL] [Abstract][Full Text] [Related]
2. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.
Mohammed A; Janakiram NB; Brewer M; Duff A; Lightfoot S; Brush RS; Anderson RE; Rao CV
Neoplasia; 2012 Dec; 14(12):1249-59. PubMed ID: 23308056
[TBL] [Abstract][Full Text] [Related]
3. Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer.
Datta J; Bianchi A; De Castro Silva I; Deshpande NU; Cao LL; Mehra S; Singh S; Rafie C; Sun X; Chen X; Dai X; Colaprico A; Sharma P; Dosch AR; Pillai A; Hosein PJ; Nagathihalli NS; Komanduri KV; Wilson JM; Ban Y; Merchant NB
Oncogene; 2022 Jul; 41(28):3640-3654. PubMed ID: 35701533
[TBL] [Abstract][Full Text] [Related]
4. TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma.
Zhou Y; Jin J; Ji Y; Zhang J; Fu N; Chen M; Wang J; Qin K; Jiang Y; Cheng D; Deng X; Shen B
J Transl Med; 2023 Dec; 21(1):872. PubMed ID: 38037073
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Driven Pancreatic Cancer.
Sun X; Yang D; Chen Y
Cells; 2023 Nov; 12(22):. PubMed ID: 37998349
[TBL] [Abstract][Full Text] [Related]
6. The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice.
Hoffman MT; Kemp SB; Salas-Escabillas DJ; Zhang Y; Steele NG; The S; Long D; Benitz S; Yan W; Margolskee RF; Bednar F; Pasca di Magliano M; Wen HJ; Crawford HC
Cell Mol Gastroenterol Hepatol; 2021; 11(2):349-369. PubMed ID: 32882403
[TBL] [Abstract][Full Text] [Related]
7. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma.
Debernardi S; Liszka L; Ntala C; Steiger K; Esposito I; Carlotti E; Baker AM; McDonald S; Graham T; Dmitrovic B; Feakins RM; Crnogorac-Jurcevic T
Mol Oncol; 2024 Mar; 18(3):677-690. PubMed ID: 38145461
[TBL] [Abstract][Full Text] [Related]
8. MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype.
Sodir NM; Kortlever RM; Barthet VJA; Campos T; Pellegrinet L; Kupczak S; Anastasiou P; Swigart LB; Soucek L; Arends MJ; Littlewood TD; Evan GI
Cancer Discov; 2020 Apr; 10(4):588-607. PubMed ID: 31941709
[TBL] [Abstract][Full Text] [Related]
9. Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation.
Hocker JR; Mohammed A; Aston CE; Brewer M; Lightfoot SA; Rao CV; Hanas JS
Int J Cancer; 2013 Dec; 133(11):2662-71. PubMed ID: 23712558
[TBL] [Abstract][Full Text] [Related]
10. Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer.
Bianchi A; De Castro Silva I; Deshpande NU; Singh S; Mehra S; Garrido VT; Guo X; Nivelo LA; Kolonias DS; Saigh SJ; Wieder E; Rafie CI; Dosch AR; Zhou Z; Umland O; Amirian H; Ogobuiro IC; Zhang J; Ban Y; Shiau C; Nagathihalli NS; Montgomery EA; Hwang WL; Brambilla R; Komanduri K; Villarino AV; Toska E; Stanger BZ; Gabrilovich DI; Merchant NB; Datta J
Cancer Discov; 2023 Jun; 13(6):1428-1453. PubMed ID: 36946782
[TBL] [Abstract][Full Text] [Related]
11. Organoids Models of Pancreatic Duct Adenocarcinoma.
Yu C; Kang R; Tang D
Methods Mol Biol; 2023; 2712():45-60. PubMed ID: 37578695
[TBL] [Abstract][Full Text] [Related]
12. Induction and characterization of pancreatic cancer in a transgenic pig model.
Boas FE; Nurili F; Bendet A; Cheleuitte-Nieves C; Basturk O; Askan G; Michel AO; Monette S; Ziv E; Sofocleous CT; Maxwell AWP; Schook LB; Solomon SB; Kelsen DP; Scherz A; Yarmohammadi H
PLoS One; 2020; 15(9):e0239391. PubMed ID: 32956389
[TBL] [Abstract][Full Text] [Related]
13. Genetically engineered mouse models of pancreatic cancer.
Westphalen CB; Olive KP
Cancer J; 2012; 18(6):502-10. PubMed ID: 23187836
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.
Sheffels E; Sealover NE; Wang C; Kim DH; Vazirani IA; Lee E; M Terrell E; Morrison DK; Luo J; Kortum RL
Sci Signal; 2018 Sep; 11(546):. PubMed ID: 30181243
[TBL] [Abstract][Full Text] [Related]
15. Pigs: Large Animal Preclinical Cancer Models.
Joshi K; Katam T; Hegde A; Cheng J; Prather RS; Whitworth K; Wells K; Bryan JN; Hoffman T; Telugu BP; Kaifi JT; Rachagani S
World J Oncol; 2024 Apr; 15(2):149-168. PubMed ID: 38545477
[TBL] [Abstract][Full Text] [Related]
16. Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses
Segatto NV; Simões LD; Bender CB; Sousa FS; Oliveira TL; Paschoal JDF; Pacheco BS; Lopes I; Seixas FK; Qazi A; Thomas FM; Chaki S; Robertson N; Newsom J; Patel S; Rund LA; Jordan LR; Bolt C; Schachtschneider KM; Schook LB; Collares TV
Front Oncol; 2024; 14():1323422. PubMed ID: 38469237
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline-dependent Cas9-expressing pig resources for conditional in vivo gene nullification and activation.
Jin Q; Liu X; Zhuang Z; Huang J; Gou S; Shi H; Zhao Y; Ouyang Z; Liu Z; Li L; Mao J; Ge W; Chen F; Yu M; Guan Y; Ye Y; Tang C; Huang R; Wang K; Lai L
Genome Biol; 2023 Jan; 24(1):8. PubMed ID: 36650523
[TBL] [Abstract][Full Text] [Related]
18. Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig.
Mondal P; Patel NS; Bailey K; Aravind S; Cartwright SB; Hollingsworth MA; Lazenby AJ; Carlson MA
Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36579622
[TBL] [Abstract][Full Text] [Related]
19. Large Animal Models of Breast Cancer.
Mondal P; Bailey KL; Cartwright SB; Band V; Carlson MA
Front Oncol; 2022; 12():788038. PubMed ID: 35186735
[TBL] [Abstract][Full Text] [Related]
20. Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer.
Principe DR; Underwood PW; Kumar S; Timbers KE; Koch RM; Trevino JG; Munshi HG; Rana A
Front Oncol; 2022; 12():806963. PubMed ID: 35155243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
